Cartesian therapeutics announces first patient dosed in phase 2 trial of descartes-08 in systematic lupus erythematosus

Trial to assess outpatient administration without lymphodepleting chemotherapy in patients with sle trial to assess outpatient administration without lymphodepleting chemotherapy in patients with sle

SLE Ratings Summary

SLE Quant Ranking